<VariationArchive VariationID="264104" VariationName="NM_000238.4(KCNH2):c.234_241del (p.Ala79fs)" VariationType="Deletion" Accession="VCV000264104" Version="13" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-06-10" DateCreated="2016-10-03" MostRecentSubmission="2024-05-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="258472" VariationID="264104">
      <GeneList>
        <Gene Symbol="KCNH2" FullName="potassium voltage-gated channel subfamily H member 2" GeneID="3757" HGNC_ID="HGNC:6251" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q36.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="150944961" stop="150978321" display_start="150944961" display_stop="150978321" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="150642043" stop="150675401" display_start="150642043" display_stop="150675401" Strand="-" />
          </Location>
          <OMIM>152427</OMIM>
          <Haploinsufficiency last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNH2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2020-02-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=KCNH2">No evidence available</Triplosensitivity>
          <Property>gene_acmg_incidental_2013</Property>
          <Property>gene_acmg_incidental_2016</Property>
          <Property>gene_acmg_incidental_2021</Property>
          <Property>gene_acmg_incidental_2022</Property>
        </Gene>
      </GeneList>
      <Name>NM_000238.4(KCNH2):c.234_241del (p.Ala79fs)</Name>
      <CanonicalSPDI>NC_000007.14:150974776:GCGCGGCAGCGCGGC:GCGCGGC</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7q36.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="150974777" stop="150974784" display_start="150974777" display_stop="150974784" variantLength="8" positionVCF="150974776" referenceAlleleVCF="TGCGCGGCA" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="150671865" stop="150671872" display_start="150671865" display_stop="150671872" variantLength="8" positionVCF="150671864" referenceAlleleVCF="TGCGCGGCA" alternateAlleleVCF="T" />
      </Location>
      <OtherNameList>
        <Name>p.Ala79AspfsTer63</Name>
      </OtherNameList>
      <ProteinChange>A79fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000238.3" sequenceAccession="NM_000238" sequenceVersion="3" change="c.234_241del8">
            <Expression>NM_000238.3:c.234_241del8</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000238.3" sequenceAccession="NM_000238" sequenceVersion="3" change="c.234_241delTGCCGCGC">
            <Expression>NM_000238.3:c.234_241delTGCCGCGC</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.150671872_150671879del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.150671872_150671879del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.150974784_150974791del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.150974784_150974791del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008916.1" sequenceAccession="NG_008916" sequenceVersion="1" change="g.8143_8150del">
            <Expression>NG_008916.1:g.8143_8150del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000238.4" sequenceAccession="NM_000238" sequenceVersion="4" change="c.234_241del" MANESelect="true">
            <Expression>NM_000238.4:c.234_241del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000229.1" sequenceAccession="NP_000229" sequenceVersion="1" change="p.Ala79fs">
            <Expression>NP_000229.1:p.Ala79fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001406755.1" sequenceAccession="NM_001406755" sequenceVersion="1" change="c.50_57delGCCGCGCT">
            <Expression>NM_001406755.1:c.50_57delGCCGCGCT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001393684.1" sequenceAccession="NP_001393684" sequenceVersion="1" change="p.Ala20Aspfs">
            <Expression>NP_001393684.1:p.Ala20Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_172056.3" sequenceAccession="NM_172056" sequenceVersion="3" change="c.227_234delGCCGCGCT">
            <Expression>NM_172056.3:c.227_234delGCCGCGCT</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_742053.1" sequenceAccession="NP_742053" sequenceVersion="1" change="p.Ala79Aspfs">
            <Expression>NP_742053.1:p.Ala79Aspfs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_176254.1" sequenceAccession="NR_176254" sequenceVersion="1" change="n.635_642delGCCGCGCT">
            <Expression>NR_176254.1:n.635_642delGCCGCGCT</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_288" sequenceAccession="LRG_288">
            <Expression>LRG_288:g.8143_8150del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_288t1" sequenceAccession="LRG_288t1">
            <Expression>LRG_288t1:c.227_234del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_288p1" sequenceAccession="LRG_288p1" change="p.Ala79Aspfs">
            <Expression>LRG_288p1:p.Ala79Aspfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_288t2" sequenceAccession="LRG_288t2">
            <Expression>LRG_288t2:c.234_241del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_288p2" sequenceAccession="LRG_288p2" change="p.Ala79fs">
            <Expression>LRG_288p2:p.Ala79fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA10587645" DB="ClinGen" />
        <XRef Type="rs" ID="886039045" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000238.4(KCNH2):c.234_241del (p.Ala79fs) AND Cardiovascular phenotype" Accession="RCV000244733" Version="5">
        <ClassifiedConditionList TraitSetID="32616">
          <ClassifiedCondition DB="MedGen" ID="CN230736">Cardiovascular phenotype</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2015-06-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000238.4(KCNH2):c.234_241del (p.Ala79fs) AND Long QT syndrome 2" Accession="RCV002463670" Version="1">
        <ClassifiedConditionList TraitSetID="3981">
          <ClassifiedCondition DB="MedGen" ID="C3150943">Long QT syndrome 2</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-11-28" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_000238.4(KCNH2):c.234_241del (p.Ala79fs) AND not provided" Accession="RCV001508226" Version="7">
        <ClassifiedConditionList TraitSetID="9460">
          <ClassifiedCondition DB="MedGen" ID="C3661900">not provided</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2020-04-13" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-11-28" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2016-10-03" MostRecentSubmission="2024-05-01">
        <ReviewStatus>criteria provided, multiple submitters, no conflicts</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">19668779</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">19716085</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23098067</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">36102233</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3981" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="6428" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Long QT syndrome 2</ElementValue>
                <XRef ID="Long+QT+syndrome+2/4300" DB="Genetic Alliance" />
                <XRef ID="MONDO:0013367" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">LQT2</ElementValue>
                <XRef Type="MIM" ID="613688" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Long QT syndrome (LQTS) is a cardiac electrophysiologic disorder, characterized by QT prolongation and T-wave abnormalities on the EKG that are associated with tachyarrhythmias, typically the ventricular tachycardia torsade de pointes (TdP). TdP is usually self-terminating, thus causing a syncopal event, the most common symptom in individuals with LQTS. Such cardiac events typically occur during exercise and emotional stress, less frequently during sleep, and usually without warning. In some instances, TdP degenerates to ventricular fibrillation and causes aborted cardiac arrest (if the individual is defibrillated) or sudden death. Approximately 50% of untreated individuals with a pathogenic variant in one of the genes associated with LQTS have symptoms, usually one to a few syncopal events. While cardiac events may occur from infancy through middle age, they are most common from the preteen years through the 20s. Some types of LQTS are associated with a phenotype extending beyond cardiac arrhythmia. In addition to the prolonged QT interval, associations include muscle weakness and facial dysmorphism in Andersen-Tawil syndrome (LQTS type 7); hand/foot, facial, and neurodevelopmental features in Timothy syndrome (LQTS type 8); and profound sensorineural hearing loss in Jervell and Lange-Nielson syndrome.</Attribute>
                <XRef ID="NBK1129" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="3285" />
                <XRef ID="3285" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301308</ID>
                <ID Source="BookShelf">NBK1129</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2013">
                <ID Source="PubMed">23788249</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2015">
                <ID Source="PubMed">25356965</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG, 2016">
                <ID Source="PubMed">27854360</ID>
                <ID Source="DOI">10.1038/gim.2016.190</ID>
              </Citation>
              <Citation Type="general" Abbrev="HRS/EHRA, 2012">
                <ID Source="PubMed">21810866</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.0, 2021">
                <ID Source="PubMed">34012068</ID>
                <ID Source="DOI">10.1038/s41436-021-01172-3</ID>
              </Citation>
              <Citation Type="general" Abbrev="ACMG SF v3.1, 2022">
                <ID Source="PubMed">35802134</ID>
                <ID Source="DOI">10.1016/j.gim.2022.04.006</ID>
              </Citation>
              <XRef ID="101016" DB="Orphanet" />
              <XRef ID="768" DB="Orphanet" />
              <XRef ID="C3150943" DB="MedGen" />
              <XRef ID="MONDO:0013367" DB="MONDO" />
              <XRef Type="MIM" ID="613688" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="9460" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="17556" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">not provided</ElementValue>
                <XRef ID="13DG0619" DB="Department Of Translational Genomics (developmental Genetics Section), King Faisal Specialist Hospital &amp; Research Centre" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">none provided</ElementValue>
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">The term 'not provided' is registered in MedGen to support identification of submissions to ClinVar for which no condition was named when assessing the variant. 'not provided' differs from 'not specified', which is used when a variant is asserted to be benign, likely benign, or of uncertain significance for conditions that have not been specified.</Attribute>
              </AttributeSet>
              <XRef ID="C3661900" DB="MedGen" />
            </Trait>
          </TraitSet>
          <TraitSet ID="32616" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33389" Type="Finding">
              <Name>
                <ElementValue Type="Preferred">Cardiovascular phenotype</ElementValue>
              </Name>
              <XRef ID="CN230736" DB="MedGen" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="3374688" SubmissionDate="2021-05-26" DateLastUpdated="2021-06-15" DateCreated="2021-06-15">
        <ClinVarSubmissionID localKey="NM_000238.3:c.234_241del8|Not provided" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001714255" DateUpdated="2021-06-15" DateCreated="2021-06-15" Type="SCV" Version="1" SubmitterName="Mayo Clinic Laboratories, Mayo Clinic" OrgID="500068" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-13">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19716085</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19668779</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23098067</ID>
          </Citation>
          <Comment>PVS1, PS3, PS4_Moderate, PM2</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="VariantAlleles" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000238.3:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Ala79Aspfs*63</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000238.3:c.234_241del8</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">Not provided</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB9741791</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="5397186" SubmissionDate="2022-12-05" DateLastUpdated="2022-12-11" DateCreated="2022-12-11">
        <ClinVarSubmissionID localKey="SUB12360891" submittedAssembly="hg19" title="SUB12360891" />
        <ClinVarAccession Accession="SCV002758012" DateUpdated="2022-12-11" DateCreated="2022-12-11" Type="SCV" Version="1" SubmitterName="Petrovsky National Research Centre of Surgery, The Federal Agency for Scientific Organizations" OrgID="505794" OrganizationCategory="laboratory" OrgAbbreviation="NRCS" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-11-28">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">36102233</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">23098067</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">19716085</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="PubMed">19668779</ID>
          </Citation>
          <Comment>Heterozygous mutation c.234_241del (p.Ala79AspfsTer63) in KCNH2 gene was found in male proband (13 y.o., Caucasian) with Long QT syndrome. This variant is absent in Genome Aggregation Database (gnomAD) (date of access 2022-11-22). Functional analysis shows this mutation leads to a loss of hERG potassium channel function (PMID: 19668779). The variant has been reported in several articles (PMID: 36102233, 23098067, 19716085, 19668779). ClinVar contains entry on this variant (Variation ID: 264104). In accordance with ACMG(2015) criteria this variant is classified as Pathogenic with following criteria selected: PVS1, PS3, PS4_moderate, PM2.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Ethnicity>Caucasian</Ethnicity>
              <Species TaxonomyId="9606">human</Species>
              <Age Type="minimum" age_unit="years">10</Age>
              <Age Type="maximum" age_unit="years">19</Age>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
            <TraitSet Type="Finding">
              <Trait ClinicalFeaturesAffectedStatus="present" Type="Finding">
                <XRef DB="HP" ID="HP:0001657" />
              </Trait>
            </TraitSet>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2">
              <Name>potassium voltage-gated channel subfamily H member 2</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000238.4:exon 2</GeneLocation>
          </Location>
          <OtherNameList>
            <Name>p.Ala79AspfsTer63</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="dbSNP" ID="rs886039045" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000238.4:c.234_241del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="613688" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12360891</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="601482" SubmissionDate="2024-04-24" DateLastUpdated="2024-05-01" DateCreated="2016-10-03">
        <ClinVarSubmissionID localKey="a886943|MedGen:CN230736" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV000319788" DateUpdated="2024-05-01" DateCreated="2016-10-03" Type="SCV" Version="7" SubmitterName="Ambry Genetics" OrgID="61756" OrganizationCategory="laboratory" OrgAbbreviation="Ambry" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2015-06-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">19668779</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">19716085</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">23098067</ID>
          </Citation>
          <Comment>The c.234_241delTGCCGCGC pathogenic mutation, located in coding exon 2 of the KCNH2 gene, results from a deletion of 8 nucleotides between positions 234 and 241, causing a translational frameshift with a predicted alternate stop codon. This mutation was detected in a proband with sports-induced syncope in childhood, atypical ECG findings, and family history which included seizures, dizziness, and abnormal ECG findings consistent with LQTS2 (Keller DI et al. Can J Cardiol 2009;25(8):455-62). In another study, this mutation was detected in two of 2500 individuals referred for LQTS-related genetic testing (Kapplinger JD et al. Heart Rhythm 2009;6(9):1297-303). In addition to the clinical data presented in the literature, since frameshifts are typically deleterious in nature, this alteration is interpreted as a disease-causing mutation (ACMG Recommendations for Standards for Interpretation and Reporting of Sequence Variations. Revision 2007. Genet Med. 2008;10:294).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Ambry Variant Classification Scheme 2023</Attribute>
          <Citation>
            <URL>https://submit.ncbi.nlm.nih.gov/api/2.0/files/i9igeqse/ambry_variant_classification_scheme_2023.pdf/?format=attachment</URL>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="KCNH2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000238.3:c.234_241delTGCCGCGC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Finding">
          <Trait Type="Finding">
            <XRef DB="MedGen" ID="CN230736" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>All AVA3 Novel and Update Variants_103122</SubmissionName>
          <SubmissionName>FinalClinVarSubmissionFile_20140101to20240315_ava3_1</SubmissionName>
          <SubmissionName>NonExomeUpdate_081220AmbryReport</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="601482" TraitType="Finding" MappingType="XRef" MappingValue="CN230736" MappingRef="MedGen">
        <MedGen CUI="CN230736" Name="Cardiovascular phenotype" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5397186" TraitType="Disease" MappingType="XRef" MappingValue="613688" MappingRef="OMIM">
        <MedGen CUI="C3150943" Name="Long QT syndrome 2" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="5397186" TraitType="Finding" MappingType="XRef" MappingValue="HP:0001657" MappingRef="HP">
        <MedGen CUI="C0151878" Name="Prolonged QT interval" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3374688" TraitType="Disease" MappingType="Name" MappingValue="Not provided" MappingRef="Preferred">
        <MedGen CUI="C3661900" Name="not provided" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

